You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 113 No. 10, October 1977 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (22)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Failure to Induce Tolerance to Mechlorethamine Hydrochloride

Steven Leshaw, MD; Roberta S. Simon, MD; Rudolf L. Baer, MD

Arch Dermatol. 1977;113(10):1406-1408.


Abstract

• In view of the contradictory results reported in the literature regarding induction of specific immunologic tolerance to mechlorethamine hydrochloride (HN2), the problem was reinvestigated using a "tolerogenic" schedule that had been reported to be effective. Mechlorethamine hydrochloride, 200 µg, intravenously, was given weekly for five weeks before beginning topical therapy with it. In the test group, five of 13 patients (11 with mycosis fungoides and two with psoriasis) became contact sensitized to mechlorethamine. In another patient, what was probably a contact urticarial reaction developed. In the control group, five of 13 patients (12 with mycosis fungoides, one with parapsoriasis) became contact sensitized to mechlorethamine. Thus, 38% of the patients in both groups became contact sensitized to mechlorethamine. It is concluded that this tolerogenic schedule, just as others previously tried, was not effective in inducing specific tolerance to mechlorethamine.

(Arch Dermatol 113:1406-1408, 1977)



Author Affiliations

From the Department of Dermatology, New York University School of Medicine, New York.


Footnotes

Accepted for publication April 13, 1977.

Reprint requests to Department of Dermatology, New York University School of Medicine, 550 First Ave, New York, NY 10016 (Dr Baer).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Prospective Study of Cutaneous Intolerance to Topical Mechlorethamine Therapy in Patients With Cutaneous T-Cell Lymphomas
Esteve et al.
Arch Dermatol 1999;135:1349-1353.
ABSTRACT | FULL TEXT  

The Treatment of Mycosis Fungoides With Ointment-Based Mechlorethamine
Price et al.
Arch Dermatol 1982;118:234-237.
ABSTRACT  

Cutaneous T-Cell Lymphomas: A Review of the Recent Literature
Zackheim
Arch Dermatol 1981;117:295-304.
ABSTRACT  

Hypersensitivity to Aloe
Morrow et al.
Arch Dermatol 1980;116:1064-1065.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1977 American Medical Association. All Rights Reserved.